大葉大學圖書館 |

Developing drug products in an aging society[electronic resource] :from concept to prescribing /

紀錄類型:	書目-電子資源 : Monograph/item
杜威分類號:	615.19
書名/作者:	Developing drug products in an aging society : from concept to prescribing // edited by Sven Stegemann.
其他作者:	Stegemann, Sven.
出版者:	Cham : : Springer International Publishing :, 2016.
面頁冊數:	xviii, 771 p. : : ill., digital ;; 24 cm.
Contained By:	Springer eBooks
標題:	Drug development.
標題:	Older people - Drug use.
標題:	Older people - Medical care.
標題:	Biomedicine.
標題:	Pharmaceutical Sciences/Technology.
標題:	Geriatrics/Gerontology.
ISBN:	9783319430997
ISBN:	9783319430973
內容註:	Healthcare provision in an aging society: US perspective -- Healthcare provision in an aging society: European perspective -- Healthcare provision in an aging society: Japanese perspective -- Old, Very Old, and Frail -- Age and the process of aging -- Comprehensive Geriatric Assessment -- Patients' clinical characteristics, disease, experience, and perception -- Ethical considerations in performing clinical trials in and for older people -- Patient reported outcomes from a clinical to a therapeutic tool -- Pharmacokinetic and Pharmacodynamic Considerations in the Elderly Population -- The Expectation of a Treatment Model: A framework for adherence and Effectiveness -- Pharmacoepidemiology and pharmacovigilance for safety and efficacy in older people -- Defining patient centric drug product design and its impact on improving safety and effectiveness -- Dosing considerations in older adults -- Oral Drug Product Use in the Elderly Patient Population -- Drug product development for older adults - multiparticulate formulations -- Considerations for topical and transdermal drug delivery in older adults -- Injectable drug delivery for older patients -- Inhalation and Nasal Formulations -- Ophthalmic drug development and the elderly -- Developing drug administration devices for use by older patients -- Manufacturing Platforms for Patient-Centric Drug Products -- Novel Manufacturing Technologies for the Production of Patient-Centric Drug Products -- Prescribing to Older Adults -- Multimorbidity and Polypharmacy -- Vaccination in Older Adults -- Medication Reviews in Older Adults -- The Personalization of Drug therapy for Elderly patients -- Importance of Clinical Nutrition in Therapy to Older Adults -- Managing drug therapy of older patients in primary and secondary care -- Medication adherence and monitoring -- Medication compounding in the provision of drug therapy -- Geriatric Pharmacotherapy: Optimisation through integrated approach in the hospital setting -- European Medicines Agency (EMA): Regulatory perspectives on geriatric medicines -- Views on the Therapeutic Needs of Older Adults -- Future Perspectives in drug therapy of older people -- Opportunities in drug product development in an aging population.
摘要、提要註:	This book aims to address the major aspects of future drug product development and therapy for older adults, giving practical guidance for the rational product and clinical development and prescribing of drug products to this ever growing segment of the population. With authors coming from key "aging" markets such as Europe, the USA, China and Japan, the book will provide valuable information for students, scientists, regulators, practitioners, and other healthcare professionals from academia, industry and regulatory bodies.
電子資源:	http://dx.doi.org/10.1007/978-3-319-43099-7

Developing drug products in an aging society[electronic resource] :from concept to prescribing /
Developing drug products in an aging societyfrom concept to prescribing /[electronic resource] :edited by Sven Stegemann. - Cham :Springer International Publishing :2016. - xviii, 771 p. :ill., digital ;24 cm. - AAPS advances in the pharmaceutical sciences series,v.242210-7371 ;. - AAPS advances in the pharmaceutical sciences series ;3..

Healthcare provision in an aging society: US perspective -- Healthcare provision in an aging society: European perspective -- Healthcare provision in an aging society: Japanese perspective -- Old, Very Old, and Frail -- Age and the process of aging -- Comprehensive Geriatric Assessment -- Patients' clinical characteristics, disease, experience, and perception -- Ethical considerations in performing clinical trials in and for older people -- Patient reported outcomes from a clinical to a therapeutic tool -- Pharmacokinetic and Pharmacodynamic Considerations in the Elderly Population -- The Expectation of a Treatment Model: A framework for adherence and Effectiveness -- Pharmacoepidemiology and pharmacovigilance for safety and efficacy in older people -- Defining patient centric drug product design and its impact on improving safety and effectiveness -- Dosing considerations in older adults -- Oral Drug Product Use in the Elderly Patient Population -- Drug product development for older adults - multiparticulate formulations -- Considerations for topical and transdermal drug delivery in older adults -- Injectable drug delivery for older patients -- Inhalation and Nasal Formulations -- Ophthalmic drug development and the elderly -- Developing drug administration devices for use by older patients -- Manufacturing Platforms for Patient-Centric Drug Products -- Novel Manufacturing Technologies for the Production of Patient-Centric Drug Products -- Prescribing to Older Adults -- Multimorbidity and Polypharmacy -- Vaccination in Older Adults -- Medication Reviews in Older Adults -- The Personalization of Drug therapy for Elderly patients -- Importance of Clinical Nutrition in Therapy to Older Adults -- Managing drug therapy of older patients in primary and secondary care -- Medication adherence and monitoring -- Medication compounding in the provision of drug therapy -- Geriatric Pharmacotherapy: Optimisation through integrated approach in the hospital setting -- European Medicines Agency (EMA): Regulatory perspectives on geriatric medicines -- Views on the Therapeutic Needs of Older Adults -- Future Perspectives in drug therapy of older people -- Opportunities in drug product development in an aging population.

This book aims to address the major aspects of future drug product development and therapy for older adults, giving practical guidance for the rational product and clinical development and prescribing of drug products to this ever growing segment of the population. With authors coming from key "aging" markets such as Europe, the USA, China and Japan, the book will provide valuable information for students, scientists, regulators, practitioners, and other healthcare professionals from academia, industry and regulatory bodies.

ISBN: 9783319430997

Standard No.: 10.1007/978-3-319-43099-7doiSubjects--Topical Terms:

339189
Drug development.

LC Class. No.: RM301.25 / .D48 2016

Dewey Class. No.: 615.19

Developing drug products in an aging society[electronic resource] :from concept to prescribing /
LDR:03841nmm a2200325 a 4500 001 467366
003 DE-He213
005 20161020180237.0
006 m d
007 cr nn 008maaau
008 170511s2016 gw s 0 eng d
020 $a 9783319430997 $q (electronic bk.)
020 $a 9783319430973 $q (paper)
024 7 $a 10.1007/978-3-319-43099-7 $2 doi
035 $a 978-3-319-43099-7
040 $a GP $c GP
041 0 $a eng
050 4 $a RM301.25 $b .D48 2016
072 7 $a TDCW $2 bicssc
072 7 $a MED072000 $2 bisacsh
082 0 4 $a 615.19 $2 23
090 $a RM301.25 $b .D489 2016
245 0 0 $a Developing drug products in an aging society $h [electronic resource] : $b from concept to prescribing / $c edited by Sven Stegemann.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2016.
300 $a xviii, 771 p. : $b ill., digital ; $c 24 cm.
490 1 $a AAPS advances in the pharmaceutical sciences series, $x 2210-7371 ; $v v.24
505 0 $a Healthcare provision in an aging society: US perspective -- Healthcare provision in an aging society: European perspective -- Healthcare provision in an aging society: Japanese perspective -- Old, Very Old, and Frail -- Age and the process of aging -- Comprehensive Geriatric Assessment -- Patients' clinical characteristics, disease, experience, and perception -- Ethical considerations in performing clinical trials in and for older people -- Patient reported outcomes from a clinical to a therapeutic tool -- Pharmacokinetic and Pharmacodynamic Considerations in the Elderly Population -- The Expectation of a Treatment Model: A framework for adherence and Effectiveness -- Pharmacoepidemiology and pharmacovigilance for safety and efficacy in older people -- Defining patient centric drug product design and its impact on improving safety and effectiveness -- Dosing considerations in older adults -- Oral Drug Product Use in the Elderly Patient Population -- Drug product development for older adults - multiparticulate formulations -- Considerations for topical and transdermal drug delivery in older adults -- Injectable drug delivery for older patients -- Inhalation and Nasal Formulations -- Ophthalmic drug development and the elderly -- Developing drug administration devices for use by older patients -- Manufacturing Platforms for Patient-Centric Drug Products -- Novel Manufacturing Technologies for the Production of Patient-Centric Drug Products -- Prescribing to Older Adults -- Multimorbidity and Polypharmacy -- Vaccination in Older Adults -- Medication Reviews in Older Adults -- The Personalization of Drug therapy for Elderly patients -- Importance of Clinical Nutrition in Therapy to Older Adults -- Managing drug therapy of older patients in primary and secondary care -- Medication adherence and monitoring -- Medication compounding in the provision of drug therapy -- Geriatric Pharmacotherapy: Optimisation through integrated approach in the hospital setting -- European Medicines Agency (EMA): Regulatory perspectives on geriatric medicines -- Views on the Therapeutic Needs of Older Adults -- Future Perspectives in drug therapy of older people -- Opportunities in drug product development in an aging population.
520 $a This book aims to address the major aspects of future drug product development and therapy for older adults, giving practical guidance for the rational product and clinical development and prescribing of drug products to this ever growing segment of the population. With authors coming from key "aging" markets such as Europe, the USA, China and Japan, the book will provide valuable information for students, scientists, regulators, practitioners, and other healthcare professionals from academia, industry and regulatory bodies.
650 0 $a Drug development. $3 339189
650 0 $a Older people $x Drug use. $3 672570
650 0 $a Older people $x Medical care. $3 439830
650 1 4 $a Biomedicine. $3 463454
650 2 4 $a Pharmaceutical Sciences/Technology. $3 464319
650 2 4 $a Geriatrics/Gerontology. $3 464039
700 1 $a Stegemann, Sven. $3 672569
710 2 $a SpringerLink (Online service) $3 463450
773 0 $t Springer eBooks
830 0 $a AAPS advances in the pharmaceutical sciences series ; $v 3. $3 466100
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-43099-7
950 $a Biomedical and Life Sciences (Springer-11642)